Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02441140 · ClinicalTrials.gov registry record · NA
Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis
A NA study, sponsored by Dana-Farber Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02441140 is a NA study that was terminated before completion, run by Dana-Farber Cancer Institute. The registered enrollment target is 5 participants.
The verdict
NCT02441140, a NA study, was terminated before completion, sponsored by Dana-Farber Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research study is studying a possible test which may help doctors diagnose women with ovarian cancer.
Interventions
- PROCEDURE Blood collection
- PROCEDURE Tissue collection
- PROCEDURE Culdocentesis
- PROCEDURE Vaginal Swab
- PROCEDURE Chromopertubation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-05 |
| Est. Completion | 2019-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02441140
The ClinicalTrials.gov registry entry for NCT02441140 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Blood collection is the first listed.
NCT02441140 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02441140 about?
NCT02441140 is a clinical study titled "Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis". This research study is studying a possible test which may help doctors diagnose women with ovarian cancer.
What is the current status of trial NCT02441140?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2015-05. Estimated completion is 2019-07.
What interventions are being tested in trial NCT02441140?
The interventions under investigation include: Blood collection (PROCEDURE), Tissue collection (PROCEDURE), Culdocentesis (PROCEDURE), Vaginal Swab (PROCEDURE), Chromopertubation (PROCEDURE).
Who is sponsoring clinical trial NCT02441140?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.